Filip Borgions
Direttore Tecnico/Scientifico/R&S presso ARGENX SE
Profilo
Dr. Filip Borgions is a Global Head-Technical Operations at argenx SE.
Dr. Borgions was previously employed as a Principal by Thrombogenics, Inc. He received his undergraduate degree from Katholieke Universiteit Leuven and a doctorate degree from Katholieke Universiteit Leuven.
Posizioni attive di Filip Borgions
Società | Posizione | Inizio |
---|---|---|
ARGENX SE | Direttore Tecnico/Scientifico/R&S | 01/01/2015 |
Precedenti posizioni note di Filip Borgions
Società | Posizione | Fine |
---|---|---|
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Corporate Officer/Principal | - |
Formazione di Filip Borgions
Katholieke Universiteit Leuven | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ARGENX SE | Health Technology |
Aziende private | 1 |
---|---|
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Commercial Services |
- Borsa valori
- Insiders
- Filip Borgions